Search for: "Market Health, Inc." Results 361 - 380 of 5,173
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Mar 2013, 8:18 pm by Prashant Reddy
The Competition Commission of India (CCI), in an order dated March 5, 2013 has dismissed, at the threshold stage, a complaint filed by a public health (HIV) activist against Gilead Inc. alleging that the company was engaged in anti-competitive activities with respect to licensing of its technologies relating to anti-HIV drugs. [read post]
27 May 2009, 4:09 am
Pfizer Inc. more than doubled its spending on lobbying in the period to $6.1 million.Earlier this month, drug makers joined doctors, insurers and hospitals in a pledge to rein in health-care cost increases by $2 trillion over the next decade. [read post]
RJ Frasca is Vice President of Marketing and Product of EBI Inc. a leading background screening provider. [read post]
(“Palmyra”) and the subsequent lease of Palmyra to Phoebe Putney Health System, Inc. [read post]
24 Nov 2009, 2:00 pm
Timco Worldwide Inc. elected to exercise an abundance of caution and initiate the recall in the interest of public health. [read post]
19 Mar 2019, 11:00 pm
Abbott is a health care company that manufactures and sells blood glucose test strips in both domestic and international markets. [read post]
18 Nov 2018, 8:30 pm by Cynthia Marcotte Stamer
  While the emphasis by the Justice Department of the market dominance of Atrium in the factual allegations contained in its complaint raise questions about whether the Justice Department would undertake similar litigation against less market dominant providers, the charges made by the Justice Department in its complaint and the agreement by Atrium to cease the challenged conduct nevertheless raise a substantial basis for concern by other health care providers and… [read post]
19 Dec 2010, 11:40 pm by Randall Reese
  The companies, which are third-generation family-owned, describe themselves as "leading producers and marketers of quality, value added poultry products to the foodservice and retail grocery markets throughout the world. [read post]
1 Sep 2010, 7:38 pm by Phillips & Cohen
Allergen, Inc., the maker of Botox Therapeutic, has agreed to plead guilty and pay $600 million, following the criminal and civil accusations that it was actively promoting Botox for “off-label” uses between 2001 and 2008.The criminal information filed indicates that Allergen substantially increased its efforts to market the Botox for off-label purposes, helping doctors to bill Medicaid and other health providers for the injections not covered by Botox’s… [read post]
2 Aug 2009, 9:56 am
The devices have been marketed since April 2007 with "no reports of adverse health consequences," the company said. [read post]
26 Aug 2021, 1:14 pm by The White Law Group
First, the investment itself is unsuitably risky because it is dependent on the overall health of specific sectors of the economy. [read post]